GLUT1 which is responsible for the transport of glucose across the blood–brain barrier, and GLUT3 which facilitates the transport of glucose into neurons, have both been found to be lowered in the brains of AD patients compared to healthy controls, and most likely contribute to the deficits in brain glucose metabolism seen in AD patients [41,42]. This evidence concerns the gene SLC2A1 and Alzheimer disease.